M. Harada
Impact in
-
- Lung Cancer Treatments and Mutations
- Lung Cancer Diagnosis and Treatment
- Oncology top 5%
- Lung Cancer Research Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lung Cancer Treatments and Mutations 11
- Lung Cancer Diagnosis and Treatment 2
- Medical Imaging and Pathology Studies 1
- Oncology 10
- Lung Cancer Research Studies 5
- Colorectal Cancer Treatments and Studies 3
- Co-authors
- Hiroshi Isobe (6 shared papers)Ichiro Kinoshita (3 shared papers)Yasuko Fujita (4 shared papers)Makoto Maemondo (6 shared papers)Akira Inoue (5 shared papers)Toshiyuki Harada (4 shared papers)Koichi Hagiwara (2 shared papers)Shunichi Sugawara (2 shared papers)
- Journals
- Annals of Oncology (7 papers)Journal of Clinical Oncology (2 papers)British Journal of Cancer (2 papers)International Journal of Oncology (1 paper)Acta Dermato Venereologica (1 paper)
- Partner nations
- JapanUnited StatesUnited Kingdom
In The Last Decade
M. Harada
20 papers receiving 965 citations
M. Harada's Hit Papers
Peers
Comparison fields: 5 of 59
- Pulmonary and Respiratory Medicine 785
- Oncology 464
- Cancer Research 123
- Microbiology 6
- Applied Microbiology and Biotechnology 11
Countries citing papers authored by M. Harada
This map shows the geographic impact of M. Harada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Harada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Harada more than expected).
Fields of papers citing papers by M. Harada
This network shows the impact of papers produced by M. Harada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Harada. The network helps show where M. Harada may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Harada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Updated overall survival results from a randomized phase III trial comparing gefitinib with carboplatin–paclitaxel for chemo-naïve non-small cell lung cancer with sensitive EGFR gene mutations (NEJ002) Hit paper breakdown → | 2012 | 428 |
| 2 | 2006 | 235 | |
| 3 | 2015 | 92 | |
| 4 | 2021 | 45 | |
| 5 | 2015 | 40 | |
| 6 | 2002 | 35 | |
| 7 | 2014 | 22 | |
| 8 | 1999 | 18 | |
| 9 | 2022 | 14 | |
| 10 | 2014 | 13 | |
| 11 | 2012 | 12 | |
| 12 | 2011 | 9 | |
| 13 | 1994 | 6 | |
| 14 | [Experimental pulmonary fibrosis induced by bleomycin]. | 1970 | 5 |
| 15 | 2014 | 3 | |
| 16 | 2024 | 2 | |
| 17 | [A giant invasive thymoma made resectable by cisplatin + vincristine + doxorubicin + etoposide (CODE)]. | 1999 | 2 |
| 18 | 2007 | 1 | |
| 19 | 2017 | 1 | |
| 20 | 2012 | 1 |
About M. Harada
M. Harada is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Molecular Biology, Cancer Research and Surgery, having authored 20 papers that have together received 984 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (5 papers), Cancer therapeutics and mechanisms (4 papers), Colorectal Cancer Treatments and Studies (3 papers), Cancer Genomics and Diagnostics (2 papers), Lung Cancer Diagnosis and Treatment (2 papers), Medical Imaging and Pathology Studies (1 paper) and Myasthenia Gravis and Thymoma (1 paper). The work is most often cited by research in Pulmonary and Respiratory Medicine (785 citations), Oncology (464 citations), Cancer Research (123 citations), Microbiology (6 citations) and Applied Microbiology and Biotechnology (11 citations). M. Harada has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Hiroshi Isobe, Ichiro Kinoshita, Yasuko Fujita, Makoto Maemondo, Akira Inoue, Toshiyuki Harada, Koichi Hagiwara, Shunichi Sugawara, Akihiko Gemma and T. Nukiwa. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, British Journal of Cancer, International Journal of Oncology and Acta Dermato Venereologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.